Virtu Financial’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Virtu Financial’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,192	Closed	-$46K	–	2316
2023 Q1	$46K	Buy	+18,192	New	+$35.9K	﹤0.01%	1117
2021 Q2	–	Sell	-10,194	Closed	-$72K	–	2238
2021 Q1	$72K	Sell	10,194 -2,218	-18%	-$16K	0.01%	1386
2020 Q4	$78K	Sell	12,412 -16,465	-57%	-$96.9K	0.01%	1126
2020 Q3	$156K	Buy	+28,877	New	+$143K	0.03%	638
2019 Q4	$103K	Buy	+25,675	New	+$89.1K	0.01%	1079
2019 Q1	–	Sell	-34,885	Closed	-$179K	–	1988
2018 Q4	$179K	Buy	+34,885	New	+$265K	0.01%	1004

Other funds holding PRTK

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Virtu Financial's PRTK Position: Q2 2023 in Review

Virtu Financial sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 18,192 shares — an estimated $46K sold.

Virtu Financial first reported a position in PRTK in Q4 2018 and held it in 6 quarters. The position peaked at $179K in Q4 2018. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.

Virtu Financial reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 18,192 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $46K.
Virtu Financial first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 6 quarters.
Virtu Financial's Paratek Pharmaceuticals, Inc. position peaked at $179K in Q4 2018.
66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.